AVDV vs IBB
Avantis International Small Cap Value ETF vs iShares Biotechnology ETF
- • AVDV has the lower expense ratio at 0.36% vs 0.44% for IBB.
- • AVDV pays a higher dividend yield (2.81%).
Side-by-side metrics
| Metric | AVDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.36% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.81% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $18.92B | $7.95B |
YTD return | 15.30% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.74 |
P/E ratio | 14.23 | 23.72 |
Last price | $107.79 | $170.10 |
Inception | — | — |
Issuer | Avantis | iShares |
AVDV top holdings
| 5706.T | Mitsui Kinzoku Co Ltd | 1.27% |
| ATS.VI | AT&S Austria Technologie & Systemtechnik AG | 1.22% |
| SPM.MI | Saipem SpA | 0.73% |
| OGC.TO | OceanaGold Corp | 0.71% |
| CLIS.TA | Clal Insurance Enterprises Holdings Ltd | 0.70% |
| PRU.AX | Perseus Mining Ltd | 0.70% |
| WHC.AX | Whitehaven Coal Ltd | 0.62% |
| DRX.L | Drax Group PLC | 0.62% |
| WCP.TO | Whitecap Resources Inc | 0.60% |
| CDE | Coeur Mining Inc | 0.59% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About AVDV
AVDV (Avantis International Small Cap Value ETF) is International developed small-cap value stocks. Managed by Avantis, the fund carries $18.9B in assets under management, an expense ratio of 0.36%, a dividend yield of 2.81%. Its largest holding is Mitsui Kinzoku Co Ltd (5706.T), which represents 1.3% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.